Zobrazeno 1 - 10
of 1 242
pro vyhledávání: '"Montalbán, C"'
Autor:
Menéndez V; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain., Solórzano JL; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., García-Cosío M; Pathology Department, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain., Alonso-Alonso R; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., Rodríguez M; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., Cereceda L; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., Fernández S; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., Díaz E; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain., Montalbán C; Hematology Department, MD Anderson Cancer Center Madrid, 28033, Madrid, Spain., Estévez M; Hematology Department, MD Anderson Cancer Center Madrid, 28033, Madrid, Spain., Piris MA; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., García JF; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain. jfgarcia@mdanderson.es.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain. jfgarcia@mdanderson.es.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain. jfgarcia@mdanderson.es.
Publikováno v:
Scientific reports [Sci Rep] 2024 Nov 11; Vol. 14 (1), pp. 27537. Date of Electronic Publication: 2024 Nov 11.
Autor:
Menéndez V; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain., Solórzano JL; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain; Pathology Department, MD Anderson Cancer Center Madrid, Madrid, Spain., García-Cosío M; Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Cereceda L; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain; Pathology Department, MD Anderson Cancer Center Madrid, Madrid, Spain., Díaz E; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain., Estévez M; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain., Roncador G; Monoclonal Antibodies and Histopathology Units, Spanish National Cancer Research Center (CNIO), Madrid, Spain., Vega Z; Monoclonal Antibodies and Histopathology Units, Spanish National Cancer Research Center (CNIO), Madrid, Spain., Montalbán C; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain., Kulasinghe A; Faculty of Medicine, Frazer Institute, The University of Queensland, Brisbane, Australia., García JF; Translational Research, MD Anderson Cancer Center Foundation, Madrid, Spain; Pathology Department, MD Anderson Cancer Center Madrid, Madrid, Spain. Electronic address: jfgarcia@mdanderson.es.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep; Vol. 37 (9), pp. 100551. Date of Electronic Publication: 2024 Jun 25.
Autor:
Solórzano JL; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain.; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Menéndez V; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Parra E; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Solis L; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Salazar R; San Agustin National University, Arequipa, Peru., García-Cosío M; Pathology Department, Hospital Ramón y Cajal, Madrid, Spain., Climent F; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain., Fernández S; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain., Díaz E; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Francisco-Cruz A; Pathology Department, National Institute of Cardiology Ignacio Chavez, México DF, Mexico., Khoury J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Jiang M; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Tamegnon A; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., Montalbán C; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain., Melero I; University of Navarra and Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain., Wistuba I; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Houston, TX, USA., De Andrea C; University of Navarra and Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain., F García J; Pathology and Molecular Department, MD Anderson Cancer Center, Madrid, Spain.; Translational Research Department, MD Anderson Foundation, Madrid, Madrid, Spain.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2024 Aug 10; Vol. 13 (1), pp. 2388304. Date of Electronic Publication: 2024 Aug 10 (Print Publication: 2024).
Autor:
Menéndez V; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain., Solórzano JL; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., García-Cosío M; Pathology Department, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain., Alonso-Alonso R; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., Rodríguez M; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., Cereceda L; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., Fernández S; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain., Díaz E; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain., Montalbán C; Hematology Department, MD Anderson Cancer Center Madrid, 28033, Madrid, Spain., Estévez M; Hematology Department, MD Anderson Cancer Center Madrid, 28033, Madrid, Spain., Piris MA; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain., García JF; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain. jfgarcia@mdanderson.es.; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain. jfgarcia@mdanderson.es.; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain. jfgarcia@mdanderson.es.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jan 06; Vol. 14 (1), pp. 710. Date of Electronic Publication: 2024 Jan 06.
Publikováno v:
In Actas Dermo-Sifiliográficas (English Edition) June 2014 105(5):438-445
Publikováno v:
In Actas dermosifiliograficas June 2014 105(5):438-445
Circulating tumor DNA for monitoring classic Hodgkin lymphoma patients: Correlation with FDG-PET/CT.
Autor:
Fernández S; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain., Cereceda L; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain.; Pathology Department MD Anderson Cancer Center Madrid Madrid Spain., Díaz E; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain., Figueroa S; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain.; Pathology Department MD Anderson Cancer Center Madrid Madrid Spain., Reguera L; Nuclear Medicine Department MD Anderson Cancer Center Madrid Madrid Spain., Menéndez V; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain., Solórzano JL; Pathology Department MD Anderson Cancer Center Madrid Madrid Spain., Montalbán C; Hematology Department MD Anderson Cancer Center Madrid Madrid Spain., Estévez M; Hematology Department MD Anderson Cancer Center Madrid Madrid Spain., García JF; Translational Research, Fundación MD Anderson International España S.L. Madrid Madrid Spain.; Pathology Department MD Anderson Cancer Center Madrid Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.
Publikováno v:
EJHaem [EJHaem] 2023 Nov 29; Vol. 5 (1), pp. 70-75. Date of Electronic Publication: 2023 Nov 29 (Print Publication: 2024).
Autor:
García-Sancho AM, Bellei M, López-Parra M, Gritti G, Cortés M, Novelli S, Panizo C, Petrucci L, Gutiérrez A, Dlouhy I, Bastos-Oreiro M, Sancho JM, Ramírez MJ, Moraleda JM, Carrillo E, Jiménez-Ubieto AI, Jarque I, Orsucci L, García-Torres E, Montalbán C, Dodero A, Arranz R, De Las Heras N, Pascual MJ, López-Jiménez J, Spina M, Re A, De Villambrosia SG, Bobillo S, Federico M, Caballero D
Publikováno v:
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare lymphoid malignancies that mostly have poor prognoses with currently available treatments. Upfront consolidation with autologous stem cell transplantation (ASCT) is frequently carr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::57cac54b56d942c0636665b4eae46f5e
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15608
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15608
Autor:
Fernández S; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Spain., Díaz E; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Spain., Rita CG; Flow Cytometry Unit, Eurofins-Megalab, MD Anderson Cancer Center Madrid, Spain., Estévez M; Department of Hematology, MD Anderson Cancer Center Madrid, Spain., Montalbán C; Department of Hematology, MD Anderson Cancer Center Madrid, Spain., García JF; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain. Electronic address: jfgarcia@mdanderson.es.
Publikováno v:
Experimental cell research [Exp Cell Res] 2023 Sep 15; Vol. 430 (2), pp. 113718. Date of Electronic Publication: 2023 Jul 17.
Autor:
Fernández S; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain., Solórzano JL; Department of Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain., Díaz E; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain., Menéndez V; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain., Maestre L; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Palacios S; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain., López M; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain., Colmenero A; Flow Cytometry Unit, Eurofins-Megalab, MD Anderson Cancer Center Madrid, Madrid, Spain., Estévez M; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain., Montalbán C; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain., Martínez Á; Cytogenetic Unit, Eurofins-Megalab, MD Anderson Cancer Center Madrid, Madrid, Spain., Roncador G; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., García JF; Translational Research Laboratory, MD Anderson Cancer Center Madrid, Madrid, Spain.; Department of Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Publikováno v:
Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 4135-4147.